PRE-APPROVAL ACCESS PROGRAMS / EXPANDED ACCESS PROGRAMS (EAP)

We strive to connect the hope of patients with the possibility of new treatments.

We live in a time that brings new discoveries more rapidly than ever before. None are more important than those leading to new and more effective treatments that provide relief for life-altering and life-threatening diseases.

For many patients, the potential benefits of new treatments remain out of reach. Barriers ranging from geographical location to complex regulations obstruct their way, and therefore, obstruct hope.

What if a treatment that holds possibility could be accessed by a physician whose patients’ quality, or even length of life could be positively impacted? What if a physician could obtain a promising new treatment for their patient who cannot participate in a clinical trial?

Caligor Coghlan Pharma Services’ Pre-Approval Access Programs offer insightful solutions by serving as a resource for companies who are researching novel treatments and healthcare providers who are seeking these treatments for their patients with unmet medical needs

I AM A…

PHARMACEUTICAL OR
BIOTECH COMPANY

LEARN MORE

PHYSICIAN

LEARN MORE

PATIENT

LEARN MORE

I AM A…

PHARMACEUTICAL OR BIOTECH COMPANY

PHYSICIAN

PATIENT